SMA TYPE I , II, III – Clinical Trials with RG7916

Spinraza was the beginning. Roche is in the development of a small molecule named RG7916 a new therapy for SMA. … Fortsätt läsa SMA TYPE I , II, III – Clinical Trials with RG7916